In Thailand, The Bangkok Post reported that BBGI, the biotechnology arm of energy conglomerate Bangchak Corporation Plc, expects a significant increase in revenue driven by key businesses such as biofuels that have a promising business outlook following Bangchak’s takeover of Esso Thailand.
The gasohol and biodiesel business alone should increase revenue by 30% this year, said the company’s chief executive and president Kittiphong Limsuwannarot.
BBGI’s push for sustainable aviation fuel (SAF) and specific enzyme production should also raise its earnings over the next two years, he said.
After the asset acquisition last year, Bangchak changed the name of Esso Thailand to Bangchak Sriracha Plc (BSRC), as it operates an oil refinery business. Bangchak continues to run its own oil refinery separately.
More on the story.
Tags: BBGI, biofuels, SAF, Thailand
Category: Fuels
